Drugs giants must help to solve the antibiotics crisis

  03 February 2020

It has been four decades since we’ve had a new class of antibiotics. Yet across the world, the number of people suffering from drug-resistant infections continues to rise at an alarming rate.

Without new antibiotics, blood poisoning, gonorrhoea and urinary tract infections, to name just three, risk becoming untreatable. More people will suffer fatal complications from routine medical procedures like chemotherapy or organ transplants. But the prospects for new treatments are more fragile than ever.

This month there has been a surge in reports on the issue. The World Health Organisation warned that there are too few drugs in the pipeline to deal with the growing threat of drug resistance. 

Further reading: The Times
Author(s): Tim Jinks
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!